Bacillus anthracis is the causative agent of anthrax in humans and other mammals 1, 2 . In lethal systemic anthrax, proliferating bacilli secrete large quantities of the toxins lethal factor (LF) and oedema factor (EF), leading to widespread vascular leakage and shock. Whereas host targets of LF (mitogen-activated protein-kinase kinases) and EF (cAMP-dependent processes) 3 have been implicated in the initial phase of anthrax 1, 2 , less is understood about toxin action during the final stage of infection. Here we use Drosophila melanogaster to identify the Rab11/Sec15 exocyst, which acts at the last step of endocytic recycling, as a novel target of both EF and LF. EF reduces levels of apically localized Rab11 and indirectly blocks vesicle formation by its binding partner and effector Sec15 (Sec15-GFP), whereas LF acts more directly to reduce Sec15-GFP vesicles. Convergent effects of EF and LF on Rab11/Sec15 inhibit expression of and signalling by the Notch ligand Delta and reduce DE-cadherin levels at adherens junctions. In human endothelial cells, the two toxins act in a conserved fashion to block formation of Sec15 vesicles, inhibit Notch signalling, and reduce cadherin expression at adherens junctions. This coordinated disruption of the Rab11/Sec15 exocyst by anthrax toxins may contribute to toxin-dependent barrier disruption and vascular dysfunction during B. anthracis infection.
B. anthracis, the aetiological agent of anthrax, secretes three factors that are required for systemic virulence [1] [2] [3] : the toxic enzymatic moieties LF and EF, and protective antigen (PA), which promotes entry of LF and EF into host cells. LF is a zinc metalloprotease that cleaves and inactivates most human mitogen-activated protein-kinase kinases (MAPKKs) 4, 5 , and EF is a potent calmodulin-dependent adenylate cyclase 6 . It has been speculated that additional host targets may contribute to mediating the lethal effects of anthrax toxins 7 and interactions between the two toxins remain poorly understood.
We chose D. melanogaster as a model system to identify new candidate pathways involved in anthrax pathogenesis. LF and EF act on conserved signalling components, MAPKKs and PKA, respectively, when expressed directly within the cells of transgenic flies, bypassing the need for PA-mediated endocytosis 8 . Here we report that strong expression of either LF or EF in the larval wing primordium also produces new, unexpected phenotypes. These phenotypes, including wing notching and thickened veins ( Supplementary Fig. 1a -c and Supplementary Fig. 2a ), are typical of mutants in the Notch signalling pathway and were strongest for EF when using the same GAL4 driver (for example, Fig. 1b , c and h, i). Consistent with these adult phenotypes, high-level expression of either toxin greatly reduced expression of the Notch target genes wg and cut ( Supplementary Fig. 1d -i). We also observed potent dose-sensitive genetic interactions between mutations in Notch pathway components and the expression of LF ( Supplementary Fig. 2b -f) or EF ( Supplementary Fig. 2g-n ).
An important unresolved issue is whether LF and EF, which are both required individually for the pathogenicity of B. anthracis, also interact in some concerted fashion 9 . We tested for toxin synergy by coexpressing them with a weak ubiquitous wing-specific GAL4 (wkG4) driver. Expression of LF alone produced no obvious phenotype (Fig. 1b , compare to wild type in a). Similarly, expression of only EF resulted in mild occasional notching of the wing margin ( Fig. 1c ), although it also caused an unrelated phenotype consisting of small wings with altered vein spacing. When EF and LF were co-expressed with this GAL4 driver, however, strong and penetrant wing margin notching phenotypes were superimposed on the EF patterning phenotype ( Fig. 1d ). Correspondingly, expression of the Notch target gene wg ( Fig. 1a-d , lower panels) and a Notch reporter construct (not shown) were greatly reduced in LF1EF wing discs. Synergy between LF and EF was also observed using other drivers, such as a strong ubiquitous GAL4 driver (stgG4) ( Fig. 1h -j) and the dpp-GAL4 driver (dppG4) (data not shown).
These initial phenotypic observations led us to examine the mechanisms underlying the Notch inhibitory effects of the anthrax toxins. Both LF (Fig. 1e , f) and EF ( Fig. 1e , g) greatly reduced levels of the Notch ligand Delta (Dl) at the apical surface of wing discs, which we confirmed by selective staining for extracellular Dl expression ( Supplementary Fig. 3a -c), and modestly decreased apical levels of Notch ( Supplementary Fig. 3g -i). EF also significantly reduced surface expression of a second Notch ligand, Serrate ( Supplementary Fig. 3d , e). We conclude that both LF and EF inhibit trafficking of Dl to the apical cell surface, diminishing Notch signalling.
Activation of Dl requires initial cell surface expression followed by endocytosis and recycling (reviewed in ref. 10) , targeting it to the adherens junction, where it engages the Notch receptor 11 . Small GTPases from the Rab family mediate specific steps of this process 12 . We expressed dominant-negative forms of each of the Drosophila Rab proteins (Rab(DN)) 13 and identified a single dominant-negative factor, Rab11(DN), which produced phenotypes virtually identical to those caused by EF ( Fig. 1i , k, Supplementary Fig. 4b, c and Supplementary  Table 1 ). Reciprocally, we co-expressed wild-type forms of each Rab with EF to determine whether increasing their dosage could rescue the Notch-like EF phenotype and found that only Rab11 could suppress EF activity ( Fig. 1l , m, compare to i; Supplementary Table 1 ). Consistent with Rab11 mediating the inhibition of Notch signalling by EF, coexpression of Rab11(DN) with EF greatly enhanced its wing phenotypes ( Fig. 1n ) and Rab11(DN), like EF, could synergize with LF to produce a stronger phenotype (Fig. 1o , similar to j). Rab11(DN) also mimicked the effect of EF in blocking Dl trafficking to the cell surface ( Supplementary Fig. 5d -f). A similar role of Rab11 in recycling endocytosed Dl to the apical cell surface has been demonstrated during sensory organ precursor cell development in Drosophila 11, 14 .
The endogenous Rab11 protein is distributed as small grainy particles just below the apical plasma membrane in wild-type wing discs 11 (Fig. 2a ). In EF-expressing discs, the level of apical Rab11 expression was greatly diminished ( Fig. 2b) appeared in basolateral areas of the cytoplasm (quantified in Supplementary Table 2 ). This finding indicates that EF acts, at least in part, by reducing the amount and/or altering the distribution of the Rab11 GTPase. Because Rab11 has been implicated in targeting other proteins to the adherens junction in addition to Notch signalling components 15 , we examined the expression of several adherens junction proteins. In wild-type wing discs, the homophylic adhesion molecule DE-cadherin (DECad) is expressed at points of cell-cell contact ( Fig. 2d) , where it colocalizes with Dl ( Supplementary Fig. 5a -c). In contrast, EF precipitously reduced DECad expression at the adherens junction ( Fig. 2e ), mimicking the effect of inhibiting Rab11 function ( Fig. 2f and Supplementary Fig. 6a, b ). This downregulation of DECad by EF could be partially rescued by co-expression with wild-type Rab11 (Supplementary Fig. 5g -i). Similar, albeit less pronounced, reductions were observed for the adherens junction proteins a-Catenin and b-Catenin (Supplementary Fig. 6d , e and g, h, respectively); however, Discs Large (Dlg) expression was unaltered ( Supplementary Fig. 6j , k), indicating that EF acts selectively and does not lead to gross disruption of adherens junction integrity per se.
As Rab11 interacts with its effector Sec15 to initiate formation of the exocyst complex, thereby leading to fusion of vesicles from the recycling endosome with the plasma membrane (reviewed in ref. 12) , we examined the effect of EF on expression of a Drosophila Sec15-GFP fusion protein construct 11 . Sec15-GFP expression has two staining components ( Fig. 2g ): large round structures near the cell surface and diffuse cytoplasmic staining. Vesicular Sec15-GFP, which corresponds to a late endocytic compartment poised to fuse with the plasma membrane 11, [16] [17] [18] , co-localized with Rab11 ( Fig. 2j and Supplementary  Fig. 7a ), consistent with the known interaction of these two proteins in the exocyst complex 11, 15, 19 . Expression of EF virtually abolished large Sec15-GFP vesicles (Fig. 2h) , and the few that remained were typically smaller than those in wild-type discs and did not co-label as strongly with Rab11 ( Supplementary Fig. 7a, b) . In contrast, the uniform cytoplasmic component of Sec15-GFP staining was largely unaltered by EF. EF probably blocks formation of large Sec15-GFP vesicles indirectly, through its effect on Rab11, because inhibition of Rab11 by Rab11(DN) (Fig. 2i ) or by RNA-mediated interference (RNAi) (data not shown) had the same effect. Furthermore, co-expression of wild-type Rab11 with EF fully rescued punctate Sec15-GFP expression ( Fig. 2k and Supplementary Fig. 8a-c) .
Because EF and LF interact synergistically in the wing and both toxins reduce access of Dl to the cell surface, we tested whether LF acted at the same recycling step as EF. Although LF did not appreciably alter Rab11 staining ( Fig. 2c ) it, like EF, nearly eliminated large Sec15-GFP vesicles ( Fig. 2l ) and residual small Sec15-GFP vesicles no longer strongly co-labelled with Rab11 ( Supplementary Fig. 7a, c) . In contrast to EF, however, the loss of Sec15-GFP staining was only weakly rescued by co-expression with wild-type Rab11 ( Supplementary Fig. 8e , f, compare to b, c for EF). LF also reduced levels of DECad at the apical cell surface ( Supplementary Fig. 6a-c) , although not as strongly as EF. Consistent with Sec15 being a mediator of LF Notch inhibitory activity, knockdown of endogenous sec15 function by RNAi caused Notch-like phenotypes in the wing ( Supplementary Fig. 9b, d) , although overexpression of wild-type sec15 had no effect ( Supplementary Fig. 9a , c). We conclude that LF and EF converge to inhibit two interacting components of the Rab11/Sec15 exocyst, resulting in reduced Notch signalling and weakened adherens junctions.
We next asked whether EF and LF could disrupt function of the wellconserved Rab11/Sec15 exocyst and its downstream effectors Notch and cadherins in mammalian systems. Established models of endothelial cell function were selected as Notch signalling has a central role in vascular remodelling (reviewed in ref. 20) , and cadherins are essential for maintaining vascular integrity 21 . We transfected a rat Sec15-GFP construct into human brain microvascular endothelial cells (hBMECs) to visualize the exocyst and observed large vesicles (Fig. 3a, d ) similar to those in Drosophila wing discs (for example, Fig. 2g ), yeast 17 and various mammalian cell types 18 . As in Drosophila, treatment with either EF toxin (EF1PA) (Fig. 3b, h) or LF toxin (LF1PA) (Fig. 3c ) greatly 
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reduced the number and size of the Sec15-GFP vesicles. Moreover, in the case of EF toxin, co-transfection of cells with human RAB11-RFP rescued the formation of large Sec15-GFP vesicles (compare Fig. 3h with i). Mirroring other systems, Rab11 and Sec15 co-localized, both in untreated ( Fig. 3e-g) and in EF-treated endothelial cells rescued with RAB11-RFP ( Fig. 3i-k) . We conclude that the EF and LF toxins function similarly in human and Drosophila cells to disrupt formation of the Rab11/Sec15 exocyst. Looking downstream of the exocyst, we found that treatment with EF toxin disrupted the strong and uninterrupted pan-cadherin (pCAD) expression found at points of cell-cell contact in untreated monolayers of hBMECs (compare Fig. 3b, h with a, d) , in primary human dermal microvascular endothelial cells (hDMECs; compare Fig. 3m with l; Supplementary Fig. 10a, b) , and in primary human lung microvascular endothelial cells (hMVEC-Ls; Supplementary Fig. 11a, b ). LF toxin had no clear effect on pCAD in hBMECs ( Fig. 3c ), although levels were moderately reduced in hDMECs ( Supplementary Fig. 10c ), which form more regular borders than hBMECs.
We also examined the effect of anthrax toxins on Notch signalling in mammalian cells. hBMECs were infected with wild-type B. anthracis Sterne bacteria, which express both EF and LF, or isogenic mutant bacteria lacking EF (DEF), LF (DLF), or both toxins (DLF1EF or DpXO1) 22 . Bacterial anthrax toxin production inhibited hBMEC expression of the Notch target gene HES1 ( Fig. 3n ; quantified in Supplementary Fig. 12a ) and RBPJ ( Supplementary Fig. 12b) , with EF exerting the dominant effect. Notch-dependent regulation of HES1 in hBMECs was confirmed using the c-secretase inhibitor DBZ (Fig. 3n ). In addition, EF toxin treatment of hDMECs or hMVEC-Ls triggered formation of large and misshapen intracellular vesicles of the endothelial-specific Notch ligand Delta-Like 4 (DLL4) (compare Fig. 3m with l and Supplementary Fig. 11a with b) as observed in Drosophila ( Fig. 1e-g) .
Because previous studies have described the effect of anthrax toxins on vascular leakage and pulmonary oedema 9,23,24 , we analysed endothelial barrier integrity using in vitro and in vivo assays during infection. Exposure to wild-type B. anthracis increased the permeability of hBMEC transwell monolayers, an effect principally dependent on EF activity (Fig. 3o) . Similarly, purified EF toxin induced dose-dependent hBMEC permeability in the same assay ( Supplementary Fig. 12c ). Next, individual mice were infected subcutaneously in adjacent locations with wild-type and mutant strains of B. anthracis 22 , followed 6 h later by intravenous injection of Evans blue dye (Miles assay 25, 26 ). Wild-type B. anthracis induced severe vascular effusion at the site of injection (Fig. 3p ), and this effect was greatly attenuated in DEF mutant bacteria, but only modestly so in DLF mutants (Fig. 3p, q) . Similarly in the lung, wild-type B. anthracis induced pulmonary oedema, indicative of pulmonary endothelial barrier dysfunction, and this effect was also abrogated in DEF mutant bacteria ( Supplementary Fig. 11c, d) .
In summary, LF and EF toxins interact synergistically in Drosophila to block Rab11/Sec15-dependent endocytic recycling, resulting in reduced Notch signalling and cadherin-dependent adhesion at the adherens junction, and these toxins produce very similar effects in mammalian cells. Failure to target proteins to the adherens junction may contribute to the loss of endothelial barrier integrity in EF-toxintreated cells and to the toxin-dependent vascular effusion caused in vivo during B. anthracis infection (see summary scheme in Fig. 3r ). The reduction in Dl/Notch levels in response to anthrax toxin treatment requires further analysis with respect to potential consequences 
on vascular integrity, which could be direct (for example, mediated by Notch-dependent regulation of factors such as VEGF or by Dl-Notch adhesion) or indirect (for example, mediated by Notch-dependent regulation of cytokine production). The precise mechanisms by which EF and LF cooperatively inhibit Rab11/Sec15 function remain to be elucidated. EF-mediated cAMP production could act on either or both of two known effectors, PKA and Epac, both of which have connections to Rab11 regulation 27, 28 . LF may function via cleavage and inactivation of its known MAPKK targets or act on novel targets. It is also unclear why EF has consistently stronger effects than LF in both flies and vertebrates, as they both converge on the exocyst. It may be that Rab11 has additional partners that act in parallel to Sec15. Alternatively, LF may block only a subset of Sec15 functions or may exert competing effects on the exocyst mediated by opposing actions of different MAPKKs or as yet unidentified targets. Future genetic dissection of these impinging pathways will be required to distinguish between these possibilities. Finally, it may be fruitful to examine whether the mammalian exocyst and its downstream effectors could also be targets of other microbial virulence factors known to increase cAMP levels, inhibit MAPKK signalling, or disrupt host barrier integrity.
METHODS SUMMARY
Drosophila genetics. Transgenic lines UAS-LF2X/FM7, UAS-LF3X/FM7 and UAS-EF UAS-Flp/TM3 were described previously 8 . UAS-Sec15-GFP was provided by H. Bellen. UAS-Rab and GAL4 lines were obtained from the Bloomington Drosophila stock centre. The UAS-sec15 RNAi stock was obtained from the Vienna Drosophila RNAi Centre (VDRC).
Immunofluorescence on imaginal discs. Imaginal disc staining involved the following antibodies: anti-Dl (clone C594.9B-c; A. Parks), rat anti-Rab11 (R. Cohen) and rat anti-Serrate (K. Irvine). Other antibodies were obtained from the Developmental Studies Hydridoma Bank (DSHB): anti-Cut (2B10-c), anti-DECad (DCAD2), anti-a-catenin (DCAT-1), anti-b-Catenin (N2 7A1), anti-Discs Large (DLG1) and anti-NotchECD (C458.2H). In situ hybridization on wing discs was performed as described 29 . hBMEC, hDMEC and hMVEC-L experiments. hBMECs 30 were infected with B. anthracis Sterne (pXO1 1 , pXO2 2 ) or isogenic mutants 22 and RNA was collected 6 h later 30 for semi-quantitative PCR and quantitative PCR. For immunofluorescence, hBMECs were transfected using 0.5 mg of DNA (rat Sec15-GFP 18 plasmid was provided by C. Mitchell and human RAB11-RFP plasmid was a gift from M. Colombo) plus 2 ml Fugene (Roche). Purified EF1PA or LF1PA (S. Leppla) were added for 24 h and fixed cells were stained using anti-pan-cadherin (pCAD) (Abcam, ab6528) or anti-Dll4 antibodies (Lifespan). For transwell assays, cells were grown on collagenized transwells (Transwell-COL) for 7 days. hDMECs (Lonza CC-2543) or hMVEC-Ls (Lonza, CC-2527) were treated with purified EF or LF toxin, fixed and stained as described earlier for hBMECs except that hMVEC-Ls were treated with EF toxin for 48 h. Vascular permeability in the skin was assessed using the Miles assay 25, 26 .
